Literature DB >> 30449478

The excess mortality risk associated with anticholinergic burden among older patients discharged from acute care hospital with depressive symptoms.

Andrea Corsonello1, Annalisa Cozza2, Sonia D'Alia2, Graziano Onder3, Stefano Volpato4, Carmelinda Ruggiero5, Antonio Cherubini6, Mirko Di Rosa2, Paolo Fabbietti2, Fabrizia Lattanzio7.   

Abstract

BACKGROUND: The relationship between anticholinergic burden and mortality is controversial, and the impact of anticholinergic burden on prognosis may vary in presence of other conditions common in old age. We aimed at investigating the role of depressive symptoms as potential effect modifiers in the association between anticholinergic burden and 1-year mortality in older patients discharged from hospital.
METHODS: Our series consisted of 576 older patients consecutively admitted to seven geriatric and internal medicine acute care wards in the context of a prospective multicenter observational study. Overall anticholinergic burden was assessed by Anticholinergic Cognitive Burden (ACB) score. Depressive symptoms were assessed by 15-item Geriatric Depression Scale (GDS). The study outcome was all-cause mortality during 12-months follow-up. Statistical analysis was carried out by Cox regression analysis.
RESULTS: After adjusting for potential confounders, discharge ACB score = 2 or more was significantly associated with the outcome among patients with GDS > 5 (HR = 3.70; 95%CI = 1.18-11.6), but not among those with GDS ≤ 5 (HR = 2.32; 95%CI = 0.90-6.24). The association was confirmed among depressed patients after adjusting for ACB score at 3-month follow-up (HR = 3.58; 95%CI = 1.21-10.7), as well as when considering ACB score as a continuous variable (HR = 1.42; 95%CI = 1.10-1.91). The interaction between ACB score at discharge and BADL dependency was statistically significant (p < .005).
CONCLUSIONS: ACB score at discharge may predict mortality among older patients discharged from acute care hospital carrying high GDS score e. Hospital physician should be aware that prescribing anticholinergic medications in such a vulnerable population may have negative prognostic implications.
Copyright © 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  15-item Geriatric Depression Scale (GDS); Anticholinergic cognitive burden (ACB); Hospital; Older; Survival

Mesh:

Substances:

Year:  2018        PMID: 30449478     DOI: 10.1016/j.ejim.2018.11.004

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  7 in total

Review 1.  Association between anticholinergic drug burden and mortality in older people: a systematic review.

Authors:  Sheraz Ali; Gregory M Peterson; Luke R Bereznicki; Mohammed S Salahudeen
Journal:  Eur J Clin Pharmacol       Date:  2019-12-12       Impact factor: 2.953

2.  Anticholinergic burden: First comprehensive analysis using claims data shows large variation by age and sex.

Authors:  Jonas Reinold; Malte Braitmaier; Oliver Riedel; Ulrike Haug
Journal:  PLoS One       Date:  2021-06-30       Impact factor: 3.240

3.  Unveiling the Burden of Interactions Among Clinical Risk Factors for 1-Year Mortality in Hospitalized Older Patients.

Authors:  Fabrizia Lattanzio; Valentina Corigliano; Luca Soraci; Alessia Fumagalli; Graziano Onder; Stefano Volpato; Antonio Cherubini; Carmelinda Ruggiero; Annalisa Cozza; Francesco Guarasci; Andrea Corsonello
Journal:  Front Med (Lausanne)       Date:  2021-11-25

4.  Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study.

Authors:  Søren Ramsdal Sørensen; Jeppe Dalskov Frederiksen; Pavithra Laxsen Anru; Tahir Masud; Mirko Petrovic; Jens-Ulrik Rosholm; Jesper Ryg
Journal:  Drugs Real World Outcomes       Date:  2021-08-19

5.  High anticholinergic burden at admission associated with in-hospital mortality in older patients: A comparison of 19 different anticholinergic burden scales.

Authors:  Angela Lisibach; Giulia Gallucci; Patrick E Beeler; Chantal Csajka; Monika Lutters
Journal:  Basic Clin Pharmacol Toxicol       Date:  2021-12-06       Impact factor: 3.688

6.  Anticholinergic Burden and Safety Outcomes in Older Patients with Chronic Hepatitis C: A Retrospective Cohort Study.

Authors:  Patricia Amoros-Reboredo; Dolors Soy; Marta Hernandez-Hernandez; Sabela Lens; Conxita Mestres
Journal:  Int J Environ Res Public Health       Date:  2020-05-26       Impact factor: 3.390

Review 7.  Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review.

Authors:  Angela Lisibach; Valérie Benelli; Marco Giacomo Ceppi; Karin Waldner-Knogler; Chantal Csajka; Monika Lutters
Journal:  Eur J Clin Pharmacol       Date:  2020-10-03       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.